Randomized controlled trial comparing the safety and efficacy ... | 合法醫療器材資訊網
由ABLumsden著作·2015·被引用22次—TheFUSIONBIOLINEheparin-coatedvasculargraft(MaquetEndovascular,Wayne,NJ)wasdevelopedtoimprovethepatencyrateassociatedwithstandard ...
Objective: Despite improvements in endovascular therapy for lower extremity arterial disease, open surgical revascularization is still required when the disease is extensive. Although autogenous vein is the conduit of choice for open femoropopliteal bypass, prosthetic grafts can be an acceptable alternative when adequate vein is not available. The FUSION BIOLINE heparin-coated vascular graft (Maquet Endovascular, Wayne, NJ) was developed to improve the patency rate associated with standard prosthetic grafts. The current study, the FINEST Trial (Comparison of Safety and Primary Patency Between the FUSION BIOLINE Heparin-Coated Vascular Graft and EXXCEL Soft ePTFE), was designed to assess the clinical outcome of heparin-coated and standard vascular grafts in a prospective, randomized, controlled, multicenter trial.
Methods: During a 25-month period ending in June 2012, 209 eligible patients scheduled ...
Fusion Bioline | 合法醫療器材資訊網
FUSION Vascular Graft from Maquet : Get Quote | 合法醫療器材資訊網
FUSION BIOLINE Vascular Grafts from Maquet | 合法醫療器材資訊網
Fusion Bioline provides significant clinical benefit over ... | 合法醫療器材資訊網
Fusion Bioline vascular graft gets CE mark | 合法醫療器材資訊網
FUSION BIOLINE Brochure | 合法醫療器材資訊網
Randomized controlled trial comparing the safety and efficacy ... | 合法醫療器材資訊網
Maquet Cardiovascular Receives European CE Mark for ... | 合法醫療器材資訊網
Outcome of the FUSION vascular graft for above | 合法醫療器材資訊網
【“邁柯唯”人工血管】許可證字號:衛署醫器輸字第023489號
器材品名:“邁柯唯”人工血管許可證字號:衛署醫器輸字第023489號註銷狀態:註銷日期:註銷理由:有效日期:2022/05/02發證日期:201...